期刊档案

Frontiers in Molecular Medicine

ISSN 2674-0095 · Frontiers Media S.A. · Switzerland

Frontiers in Molecular Medicine 完全开放获取,收取 APC,金额未公布,近 24 个月 31 篇文章投稿到接收中位 57 天,2025 年发文 17 篇。

影响因子—暂无公布值
中科院分区—未被分区表收录
CiteScore 分区—暂无 CiteScore 排名
审稿周期57 天投稿到接收中位数 · 近 24 个月 31 篇文章 · PubMed
版面费收取 APC,金额未公布完全开放获取
录用比例—暂无反馈
年发文量17 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Frontiers in Molecular Medicine 由 Frontiers Media S.A. 出版。按 OpenAlex 近年发文统计,该刊主要发表 Virus-based gene therapy research、Immunotherapy and Immune Responses、CAR-T cell therapy research 等主题的论文,这 3 个主题约占 27%,主导子领域为 Molecular Biology。(根据 OpenAlex 主题统计与中科院分区数据生成)

Frontiers in Molecular Medicine is a PubMed Central indexed multidisciplinary journal, that explores the mechanisms of human diseases, and advances in diagnostics using cutting-edge technologies to promote cyclical innovation for human health care. Led by Field Chief Editor Dr Masaru Katoh (National Cancer Center, Japan), this DOAJ and PubMed Central indexed journal welcomes research contributions in the various domains of molecular medicine, bridging the gap between scientific discoveries and their practical applications. The journal welcomes original research articles, comprehensive review articles, and foresighted editorials that might lead to understanding human pathologies and the development of diagnostics and therapeutics in the future. Topics include, but are not limited to: bioinformatics and artificial intelligence for molecular medicine gene and virotherapy molecular mechanisms of neurodegeneration molecular medicine and cancer treatment molecular medicine for cardiology molecular microbes, disease and mechanisms of immune response molecular pathology. Frontiers in Molecular Medicine is particularly interested in transdisciplinary approaches spanning artificial intelligence, clinical bioinformatics, complete-genome sequencing, digital imaging, engineered animal models, gene editing, liquid biopsy, patient-derived organoids, pluripotent stem cells, single-cell analyses, and spatial biology. Furthermore, studies on cancers, cardiovascular diseases, infectious diseases, and neurodegenerative diseases are representative targets of our Journal, while other rare diseases are also within scope. In particular, the journal welcomes submissions which support the advance of the UN’s Sustainable Development Goals (SDGs), notably SDG 3: ensure healthy lives and promote well-being for all at all ages. As well as original research papers, the journal welcomes brief research reports, corrections, data reports, editorials, general commentaries, hypothesis & theory, methods, mini reviews, opinions, perspectives, reviews, technology and codes. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Frontiers in Molecular Medicine is committed to advancing developments in the field of molecular medicine by allowing unrest

摘自期刊官网 Aims & Scope

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Virus-based gene therapy researchBiochemistry, Genetics and Molecular Biology9.9%
  2. Immunotherapy and Immune ResponsesImmunology and Microbiology8.5%
  3. CAR-T cell therapy researchMedicine8.5%
  4. Cancer Immunotherapy and BiomarkersMedicine6.4%
  5. Neuroinflammation and Neurodegeneration MechanismsNeuroscience6.4%
  6. RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology5%
  7. Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.3%
  8. T-cell and B-cell ImmunologyImmunology and Microbiology3.6%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)未收录

该期刊未被此版本分区表收录。

《新锐期刊分区表》( 2026年3月发布)未收录

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

DOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

PMC出版商官网

其他:EBSCO、ProQuest、Dimensions、CNKI、CLOCKSS、Crossref

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

h-index
16OpenAlex ·
i10-index
31OpenAlex ·
两年平均被引
3.09OpenAlex ·
Gold OA 文章占比
0%LetPub ·

发文规模

年下载量(出版商公布)
149,100出版商官网 ·

逐年发文量 OpenAlex 统计 · 累计 107 篇 · 当年数据不完整

年份发文量其中 OA被引
20261919338
20251717266
20241010145
2023303069
2022272714
2021440

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

文章统计的审稿周期 PubMed 登记的稿件日期 · 至

57 天投稿到接收中位数 · P25–P75 22 天 – 75 天

接收到上线
中位数 22 天(31 篇)
投稿到上线
中位数 75 天
样本
31 篇有投稿与接收日期的文章(窗口内共 31 篇),最近一篇接收于

只统计最终被录用并发表的文章,不含被拒稿件的处理时间,因此通常长于出版商公布的"首次决定时间"。

其他来源

平均审稿速度(社区反馈)
15 WeeksLetPub ·
投稿到发表(期刊自报)
约 15 周DOAJ ·
评审方式
单盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取DOAJ

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
DOAJCHF 1,950有CC BY
OpenAlexCHF 1,950——
LetPubUSD 2,125有—

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点3 项,摘自作者指南
关键词
5–8 个
参考文献格式
Harvard 格式
稿件模板
提供 LaTeX 与 Word 模板
出版商官网 · 模型提取,逐项与原文核对
官网政策摘录AI 使用、利益冲突、出版伦理、许可与版权、开放获取、同行评审
AI 使用 Use of AI to create written or visual content

作者不得将生成式人工智能列为共同作者或作者,若使用了AI生成或编辑的内容,作者须遵守Frontiers的相关政策并对其事实准确性负责。 模型中文摘要

Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…

原文 ↗出版商官网 ·
利益冲突 Safeguards against financial conflicts of interest

由非Frontiers职员的副主编根据外部审稿人的评审作出录用决定,他们不因录用稿件获得经济激励。 模型中文摘要

Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…

原文 ↗出版商官网 ·
出版伦理

Frontiers要求投稿稿件达到国际英语语言标准方可考虑发表。 模型中文摘要

Frontiers requires manuscripts submitted to meet international English language standards to be considered for publication.

原文 ↗出版商官网 ·
许可与版权 Open access and copyright

自2012年7月起,所有Frontiers文章以CC-BY 4.0许可开放获取,作者保留版权,内容在注明出处后可自由使用。 模型中文摘要

All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…

原文 ↗出版商官网 ·
开放获取 Open access and copyright

自2012年7月起,所有Frontiers文章以CC-BY 4.0许可开放获取,作者保留版权,内容在注明出处后可自由使用。 模型中文摘要

All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…

原文 ↗出版商官网 ·
同行评审 Peer review

Frontiers采用严格透明的同行评审流程,结合专家评审与建设性对话以完善稿件。 模型中文摘要

Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Frontiers Media S.A.
出版国家或地区
Switzerland
出版语言
English
ISSN
2674-0095
官方链接

常见问题

关于 Frontiers in Molecular Medicine 的常见问题

Frontiers in Molecular Medicine 的审稿周期多长?

按 2024年10月至2026年10月(近 24 个月)31 篇已发表文章登记的日期,投稿到接收的中位数为 57 天(四分位 22–75 天);投稿社区反馈的平均审稿速度为约 15 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Frontiers in Molecular Medicine 的投稿格式要求是什么?

据期刊作者指南:关键词:5–8 个;参考文献格式:Harvard 格式;稿件模板:提供 LaTeX 与 Word 模板。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Frontiers in Molecular Medicine 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Frontiers in Molecular Medicine 被 DOAJ 收录。期刊官网自述还被 PMC 收录,该清单未与各数据库逐一核对。

Frontiers in Molecular Medicine 是开放获取期刊吗?版面费多少?

Frontiers in Molecular Medicine 为完全开放获取。收取 APC,金额未公布。

来源与更新

本页事实来自 LetPub、OpenAlex、出版商官网、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。